Top compounds associated with response to NSDHL


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K33514849 CTRPv2 pan-cancer AAC -0.061 0.7
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.016 0.7
mRNA elocalcitol CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.017 0.7
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.015 0.7
mRNA paclitaxel FIMM pan-cancer AAC 0.061 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA BRD-K41334119 CTRPv2 pan-cancer AAC -0.034 0.7
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.015 0.7
mRNA temsirolimus FIMM pan-cancer AAC 0.071 0.7
Download CSV